Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Type I interferon in the pathogenesis of systemic lupus erythematosus

Full text
Author(s):
Postal, Mariana [1] ; Vivaldo, Jessica F. [1, 2] ; Fernandez-Ruiz, Ruth [3] ; Paredes, Jacqueline L. [3] ; Appenzeller, Simone [1, 4] ; Niewold, Timothy B. [3]
Total Authors: 6
Affiliation:
[1] Univ Estadual Campinas, Sch Med Sci, Autoimmun Lab, Campinas, SP - Brazil
[2] Univ Estadual Campinas, Sch Med Sci, Grad Program Child & Adolescent Hlth, Campinas, SP - Brazil
[3] NYU, Sch Med, Colton Ctr Autoimmun, New York, NY - USA
[4] Univ Estadual Campinas, Sch Med Sci, Dept Med, Rheumatol Unit, Campinas, SP - Brazil
Total Affiliations: 4
Document type: Review article
Source: CURRENT OPINION IN IMMUNOLOGY; v. 67, p. 87-94, DEC 2020.
Web of Science Citations: 0
Abstract

Type I interferon (IFN) is a primary pathogenic factor in systemic lupus erythematosus (SLE). Gain-of-function genetic variants in the type I IFN pathway have been associated with risk of disease. Common polygenic as well as rare monogenic influences on type I IFN have been demonstrated, supporting a complex genetic basis for high IFN in many SLE patients. Both SLE-associated autoantibodies and high type I IFN can be observed in the pre-disease state. Patients with SLE and evidence of high type I IFN have more active disease and a greater propensity to nephritis and other severe manifestations. Despite the well-established association between type I IFN and SLE, the specific triggers of type I IFN production, the mechanisms by which IFNs help perpetuate the cycle of autoreactive cells and autoantibody production are not completely clear. This review provides an updated overview of type I IFN in SLE pathogenesis, clinical manifestations, and current therapeutic strategies targeting this pathway. (AU)

FAPESP's process: 08/02917-0 - Blood and cerebrospinal fluid biomarkers associated with structural and functional central nervous system abnormalities in systemic lupus erythematosus
Grantee:Simone Appenzeller
Support Opportunities: Research Grants - Young Investigators Grants
FAPESP's process: 16/23269-3 - MicroRNAs of TNFa gene in systemic lupus erythematosus: potential biomarkers
Grantee:Mariana Postal Zink de Souza
Support Opportunities: Scholarships in Brazil - Post-Doctoral